NCT04402840View on ClinicalTrials.gov

Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Acute Respiratory Distress SyndromeCOVID-19
Interventions
PROCEDURE

Stellate Ganglion Block

The procedure will be done at the bedside in the ICU without interfering with ongoing treatment.

Trial Locations (1)

26506

West Virginia University Rockefeller Neuroscience Institute, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER

NCT04402840 - Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) | Biotech Hunter | Biotech Hunter